Osteoporosis Treatment After Hip Fracture: Missed Opportunities

Ferris, Mary Elina
June 2010
Internal Medicine Alert;6/15/2010, Vol. 32 Issue 11, p84
The article presents the author's insights on the study by L. A. Jennings and colleagues regarding the treatment of osteoporotic hip fracture, wherein she relates the potential use of once-yearly infusions in subsequent fractures reduction.


Related Articles

  • Annual infusion treats osteoporosis.  // British Journal of Hospital Medicine (17508460);May2009, Vol. 70 Issue 5, p257 

    The article reports on the significance of annual infusion of five milligrams of zoledronic acid. It states that the once a year infusion of zoledronic acid is more effective in treating and preventing the bone loss in both men and women, caused by glococorticorticoid-induced osteoporosis. It...

  • Zoledronic Acid Treatment of Osteoporosis: Effects in Men. Melissa Williams; Valentina Petkov // Endocrine Practice;Nov2010, Vol. 16 Issue 6, p960 

    Objective: To study changes in bone mineral density (BMD) and a bone resorption marker in elderly men who received off-label zoledronic acid for osteoporosis treatment.Methods: We conducted a retrospective review of medical records of 50 male veterans who had received at least one 4-mg...

  • Criteria for nursing home-based infusion therapy. Riley, Sheryl A. // Nursing Homes: Long Term Care Management;May94, Vol. 43 Issue 4, p39 

    Examines the implementation of infusion therapy programs in nursing homes. Criteria in judging an infusion therapy program; Opportunities for crossover into other programs.

  • R.Ph.s can facilitate smooth home infusion of antibiotics. Gannon, Kathi // Drug Topics;10/10/94, Vol. 138 Issue 19, p54 

    Discusses the proper management of antibiotic administration as part of home infusion therapy. Cost containment; Compliance rates in-hospital and at home; Prescription responsibilities of pharmacists.

  • Could there be savings in gravity drip infusion? It's a heavy topic. Souhrada, Laura // Materials Management in Health Care;May96, Vol. 5 Issue 5, p60 

    Explores the issues involve in hospitals' decision to abandon gravity drip infusion in favor of high-technology pumps for infusion therapy. Long-term cost implications; ECRI's proposal that its client set policies that identify gravity grip infusion applications and encourage its use when...

  • IPO infusion pumps maker of drug delivery system. Gross, Daniel // Crain's Chicago Business;9/16/96, Vol. 19 Issue 38, p31 

    Reports on the plan of computer software firm Sabratek Corp. to reduce health care costs in the United States through infusion therapy. Creation of the virtual hospital room; Method of monitoring patients; Growth of the home-infusion market; Competition faced by the company.

  • Correction: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma.  // Annals of Internal Medicine;2/17/2009, Vol. 150 Issue 4, p292 

    A correction to the article "Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma" is presented.

  • Dialysate Iron Therapy: A Potential Alternative to IV Iron Dextran.  // Kidney;Nov/Dec99, Vol. 8 Issue 6, p262 

    Evaluates the safety and efficacy of dialysate iron therapy or infusing soluble ferric pyrophosphate by dialysis, to replenish ongoing iron losses. Stabilization of maintenance dialysis patients receiving erythropoietin with maintenance intravenous (IV) iron dextran; Weekly dose of IV iron...

  • Infusion pump update. Skokal, Wendy A.; Moore, Amy Slugg // RN;Oct97, Vol. 60 Issue 10, p35 

    Presents an overview of infusion pumps on the market for 1997. Information on infusion regulation; Features of these devices; How these devices simplify intravenous (IV) therapy; How to determine which device is best. INSET: What's new in infusion pumps..


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics